A 75998

Drug Profile

A 75998

Latest Information Update: 31 Jan 2013

Price : $50

At a glance

  • Originator Abbott Laboratories
  • Class Antihormones; Peptides
  • Mechanism of Action Gonadotropin releasing hormone inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Female infertility; Male infertility; Prostate cancer

Most Recent Events

  • 31 Dec 2010 Discontinued - Phase-I for Prostate cancer in USA (unspecified route)
  • 31 Dec 2010 Discontinued - Phase-I for Male infertility in USA (unspecified route)
  • 31 Dec 2010 Discontinued - Phase-I for Female infertility in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top